S22-RT30 is a synthetic, long-acting peptide studied for its activity at three metabolic signaling receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors.
Preclinical and clinical research has examined this triple-receptor activity for its potential influence on metabolic signaling, glucose regulation, appetite-related pathways, energy expenditure, and body-weight regulation. Researchers continue to investigate its pharmacological properties, efficacy, safety, and possible applications in metabolic research.
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight: Approximately 4,731.34 g/mol
Form: Lyophilized peptide
Purity: Above 99%
For research use only. Not for human or veterinary use. This product is not intended to diagnose, treat, cure, or prevent any disease. S22-RT30 is an investigational research compound and has not been approved by the FDA.
Reviews
There are no reviews yet.